These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11196536)

  • 21. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
    Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
    Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of lymphocytes by BAT and anti CTLA-4: comparison of binding to T and B cells.
    Raiter A; Novogrodsky A; Hardy B
    Immunol Lett; 1999 Aug; 69(2):247-51. PubMed ID: 10482359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human anti-pig T cell response by anti-CD2, anti-CD40L, and CTLA4-Ig: a comparative study.
    Xu Y; Ryan D; Wu C; Bazin H; Latinne D; White-Scharf ME; Thall AD
    Transplant Proc; 2000 Aug; 32(5):926. PubMed ID: 10936275
    [No Abstract]   [Full Text] [Related]  

  • 25. The new immunology--the end of immunosuppressive drug therapy?
    Schwartz RS
    N Engl J Med; 1999 Jun; 340(22):1754-6. PubMed ID: 10352169
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunopathology and the gene therapy of lupus.
    Mageed RA; Prud'homme GJ
    Gene Ther; 2003 May; 10(10):861-74. PubMed ID: 12732872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inducing unresponsiveness by the use of anti-CD3 immunotoxin, CTLA4-Ig, and anti-CD40 ligand.
    Knechtle SJ; Kirk AD; Fechner JH; Hong X; Dong Y; Hamawy MM; Harlan DM
    Transplant Proc; 1999 May; 31(3B Suppl):27S-28S. PubMed ID: 10330966
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of T cell costimulation: an emerging therapeutic strategy for autoimmune rheumatic diseases.
    Daikh DI; Gillis J; Wofsy D
    Arthritis Rheum; 2006 Apr; 55(2):322-4. PubMed ID: 16583382
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-CTLA-4 human scFv antibodies prevent T-cell activation in transplantation.
    Pistillo MP; Tazzari PL; Stirpe F; Bolognesi A; Polito L; Capanni P; Pioli C; Gatta L; Ubaldi V; Doria G; Conte R; Ferrara GB
    Transplant Proc; 2001; 33(1-2):285-7. PubMed ID: 11266822
    [No Abstract]   [Full Text] [Related]  

  • 30. The contributions of T-cell anergy to peripheral T-cell tolerance.
    Lechler R; Chai JG; Marelli-Berg F; Lombardi G
    Immunology; 2001 Jul; 103(3):262-9. PubMed ID: 11454055
    [No Abstract]   [Full Text] [Related]  

  • 31. Releasing the brakes on antitumor immune response.
    Pardoll D
    Science; 1996 Mar; 271(5256):1691. PubMed ID: 8596929
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular mechanisms involved in T-B interactions.
    Lane P
    Chem Immunol; 1997; 67():1-13. PubMed ID: 9212494
    [No Abstract]   [Full Text] [Related]  

  • 33. Eleventh annual Pezcoller Symposium: molecular horizons in cancer therapeutics.
    Mihich E; Livingston D
    Cancer Res; 2000 Feb; 60(3):768-73. PubMed ID: 10676667
    [No Abstract]   [Full Text] [Related]  

  • 34. CTLA-4: From conflict to clinic.
    Bashyam H
    J Exp Med; 2007 Jun; 204(6):1243. PubMed ID: 17632849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 15-Deoxyspergualin (a new guanidine-like drug) blocks T lymphocyte proliferation.
    Falk W; Ulrichs K; Müller-Ruchholtz W
    Transplant Proc; 1987 Oct; 19(5):4239-40. PubMed ID: 2960051
    [No Abstract]   [Full Text] [Related]  

  • 36. Suppression of lectin, alloantigen, and xenoantigen-induced T-cell proliferation by Genistein.
    Rapaport FT; Terashima T; Tsukuda K; Kono K; Takayama T; Malinowski K
    Transplant Proc; 1997; 29(1-2):1261-4. PubMed ID: 9123297
    [No Abstract]   [Full Text] [Related]  

  • 37. The strange case of TGN1412.
    Farzaneh L; Kasahara N; Farzaneh F
    Cancer Immunol Immunother; 2007 Feb; 56(2):129-34. PubMed ID: 16783575
    [No Abstract]   [Full Text] [Related]  

  • 38. The T cell enigma in lupus.
    Dayal AK; Kammer GM
    Arthritis Rheum; 1996 Jan; 39(1):23-33. PubMed ID: 8546735
    [No Abstract]   [Full Text] [Related]  

  • 39. T cell activation through CD3 molecules in patients with systemic lupus erythematosus.
    Kaneoka H
    Arthritis Rheum; 1992 Nov; 35(11):1401-2. PubMed ID: 1445465
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibitory effect of human chorionic gonadotrophin on lymphocyte blastogenic response to mitogen, antigen and allogeneic cells.
    Han T
    Clin Exp Immunol; 1974 Dec; 18(4):529-35. PubMed ID: 4283121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.